The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ

Overview

This investigation is designed to evaluate the performance (leak and comfort) as well as the participant's overall acceptance of the nasal pillows mask amongst Obstructive Sleep Apnea (OSA) participants. Also to assist in the development process it would be beneficial to get feedback from users on certain aspects of the design. The aim of this investigation is to get feedback on the first impressions (look and feel) from users of nasal pillows PAP therapy. A total number of 15 participants who currently use a nasal pillows mask will be recruited for the trial. Participants from previous NZ trials may be recruited into this trial with their consent. All the participants will be recruited from the Fisher & Paykel Healthcare Database of subjects with OSA (Ethics Reference NTY/08/06/064), Auckland District Health Board (ADHB) and New Zealand Respiratory and Sleep Institute (NZRSI). Participants will undergo an overnight polysomnography session at the Fisher & Paykel Healthcare sleep lab. The participant will use the trial device on their usual Continuous or Auto Positive Airway Pressure (CPAP/APAP) setting and device for the duration of the overnight in-lab study.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: May 2016

Interventions

  • Device: New Nasal Pillows Mask
    • Nasal Pillows mask for the treatment of obstructive sleep apnea (OSA)

Arms, Groups and Cohorts

  • Experimental: New Nasal Pillows Mask
    • Participants to use nasal pillows mask one night in lab overnight polysomnography.

Clinical Trial Outcome Measures

Primary Measures

  • First Initial Impressions of the Toffee Nasal Pillows Mask Assessed Using a Custom Questionnaire
    • Time Frame: 12 hours
    • Participants choose the Toffee mask based on first impressions over 3 market leading masks.

Secondary Measures

  • Comfort of the Toffee Nasal Pillows Mask Assessed Using a Custom Questionnaire
    • Time Frame: 12 hours
    • Participants consider the Toffee mask to be as comfortable, or much more comfortable than their usual mask.
  • Usability of the Toffee Nasal Pillows Mask Assessed With Visual Observations
    • Time Frame: 12 hours
    • Participants consider the Toffee mask to be easier or much easier to fit and adjust than their current mask

Participating in This Clinical Trial

Inclusion Criteria

  • Adult (18+ years of age) – Able to give consent – AHI ≥ 5 on diagnostic night – Prescribed a CPAP device after successful OSA diagnosis – Existing nasal pillows mask user Exclusion Criteria:

  • Inability to give consent – Patients who are in a coma or a decreased level of consciousness. – Anatomical or physiological conditions making APAP therapy inappropriate – Commercial drivers who are investigated by New Zealand Transport Agency (NZTA) – Current diagnosis of CO2 retention – Pregnant or may think they are pregnant.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Fisher and Paykel Healthcare
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Bhavi Ogra, BSc, Principal Investigator, Sponsor Employee

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.